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Abstract
This report summarizes the outcomes of a meeting on cystic echinococcosis (CE) in animals and humans in Chile
held in Santiago, Chile, between the 21st and 22nd of January 2016. The meeting participants included
representatives of the Departamento de Zoonosis, Ministerio de Salud (Zoonotic Diseases Department, Ministry of
Health), representatives of the Secretarias Regionales del Ministerio de Salud (Regional Department of Health,
Ministry of Health), Instituto Nacional de Desarrollo Agropecuario (National Institute for the Development of
Agriculture and Livestock, INDAP), Instituto de Salud Pública (National Institute for Public Health, ISP) and the
Servicio Agrícola y Ganadero (Animal Health Department, SAG), academics from various universities, veterinarians
and physicians. Current and future CE control activities were discussed. It was noted that the EG95 vaccine was
being implemented for the first time in pilot control programmes, with the vaccine scheduled during 2016 in two
different regions in the South of Chile. In relation to use of the vaccine, the need was highlighted for acquiring
good quality data, based on CE findings at slaughterhouse, previous to initiation of vaccination so as to enable
correct assessment of the efficacy of the vaccine in the following years. The current world’s-best-practice
concerning the use of ultrasound as a diagnostic tool for the screening population in highly endemic remote and
poor areas was also discussed.
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Abbreviations: INDAP, National Institute for the Development of Agriculture and Livestock (Instituto Nacional de
Desarrollo Agropecuario); ISP, National Institute for Public Health (Instituto de Salud Pública); SAG, Animal Health
Department (Servicio Agrícola y Ganadero); CE, Cystic echinococcosis; RM, Metropolitan Region (Region Metropolitana);
US, ultrasound; MRI, Magnetic resonance imaging; CT, Computerised tomography
Background
Cystic echinococcosis (CE) remains as an important
health problem affecting animals and humans in Chile
[1, 2]. A variety of biogeographic areas are present in
Chile in a long and narrow strip of land (4,300 km long).
The country is divided into fifteen administrative
regions, including the capital, Santiago, which is usually
referred as “Region Metropolitana” (RM). Currently, the
estimated incidence for CE in humans in Chile is
1.4–1.8/100,000 [2] (see Fig. 1 for a detailed explanation
of prevalence by region). However, based on CE cases
discharged from hospitals the incidence raises to num-
bers between 4.7–5.0/100,000 indicating an important
level of underreporting of the disease in Chile [2]. In the
case of livestock animals, Echinococcus granulosus is the
second most important cause of condemnation of
viscera in abattoirs in Chile, after Fasciola hepatica. Data
from 2014 acquired at official abattoirs show a national
CE incidence of 305/1,000 animals for goats; 200 cases/
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1,000 animals for cattle; 31/1,000 for sheep; 12/1,000 ani-
mals for horses; for porcine hosts the rate is lower than 1
case/1,000 animals [3]. The most affected regions are Los
Lagos, Araucania, Los Rios, Aysen and Magallanes [2].
Regarding dog infections with E. granulosus, the informa-
tion is scarce with no data available at a national level. An
arecoline-purge survey of 1,358 dogs showed an infection
of 11% in 2000 in El Maule region (central area of Chile)
[4], while another arecoline survey in 228 dogs from
Magallanes region (southern area of Chile, under control)
found a prevalence of canine echinococcosis of 1.8% in
2001 [5]. More recently, 13.6% of dog faeces from 596
farms were positive using copro-PCR in Lonquimay
(Araucania region) [6]. Another study performed in
Coquimbo region (northern area of Chile) in 2014,
showed a high prevalence in dogs from rural and
Fig. 1 Map of Chile showing its administrative division in fifteen regions with their respective names. Grayscale colours indicate the incidence of
human cystic echinococcosis per 100,000 based on data from 2015
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urban areas (between 3.5–11.7%) using coproantigen test
[7]. A second study, using similar methodology, showed a
higher rate of infection, 28% in rural areas of five munici-
palities from the Coquimbo region [8]. In terms of mo-
lecular studies on E. granulosus isolates in Chile, a single
case of human infected with the genotype G6 has been
reported in a study in which 19 other human samples
were found to be E. granulosus (sensu stricto) (s.s.) [9]. A
second study confirmed the presence of E. granulosus
(s.s.) in cattle from the South of Chile [10].
At the moment there is no official national programme
for the control of E. granulosus. However, local control
plans (based on specific regions) have been undertaken
intermittently during the last 30 years, financially sup-
ported with national and regional funds. One of the most
relevant and successful local control programmes was
developed in the Magallanes region between 1979–2004.
The area is characterized by large population of sheep,
numbering 2,205,477 in 2007. During the time the control
plan was in action it was possible to achieve a significant
reduction of the sheep infection from 60% in 1978 to 0.7%
in 2004 and in dogs from 71.4 to 0.5%, respectively [5, 11].
Although the programme was highly successful, it
was interrupted in 2004 and there was no plan imple-
mented to maintain the low prevalence achieved.
Since 2015 four different control programmes have
been initiated in different regions of the country:
Coquimbo, Bio Bio, Araucania and Aysen. Some of
these initiatives include pilot sheep vaccination trials
with the commercial version of the EG95 vaccine
planned to be implemented in 2016.
Objectives of the meeting
The new initiatives for the control of CE that started in
2015 motivated a group of scientists in Chile having a spe-
cial interest in CE to organize a meeting related to the
control of this disease. The principal objective of the
meeting was to bring together the different groups work-
ing on CE in Chile, especially those working on control of
the transmission of the disease, to share information, ex-
perience and to enhance collaboration. The timely visit of
one of the international speakers, Melbourne Laureate
Professor Marshall Lightowlers, in the year in which the
vaccine EG95 was thought to be in use in pilot activities
in some regions in Chile, was a perfect opportunity to
reinforce the achievements of the objectives proposed by
us, including: (i) Provide a forum in which local author-
ities in charge of control programmes could exchange
their knowledge of the epidemiology of the disease with
the scientific community, other governmental institutions
and with professionals and students of health related pro-
fessions; (ii) Academics could update current knowledge
and world’s-best-practice concerning E. granulosus control
tools (e.g. aspects concerning the application of anthel-
mintics in dogs and use of the EG95 vaccine in livestock)
and the use of ultrasound as a diagnostic tool for the
screening population in highly endemic remote and poor
areas; (iii) Establish a study group for cystic
Fig. 2 Members of the organizing committee of the first meeting “Cystic echinococcosis in Chile, update in alternatives for control and diagnostics in
animals and humans”. From left to right: Dr. Fernando Fredes, Dr. Marisa Torres, Dr. Sandra Cortes, Dr. Francesca Tamarozzi (International speaker), Dr.
Rodolfo Paredes, Dr. Cristian A. Alvarez Rojas, Professor Marshall Lightowlers (International speaker) and Dr. Gerardo Acosta-Jamett
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echinococcosis in Chile. Figure 2 shows the members of
the organizing committee plus the international speakers
Professor Marshall Lightowlers and Dr. Francesca Tamar-
ozzi. The meeting was organized in four main sections
which are described below together with highlights of
each session.
Section 1: General aspects of the epidemiology of E.
granulosus in Chile
Dr. Carla Barrientos (Ministry of Health of Chile) presented
epidemiological data concerning the current situation of
human CE in Chile, including incidence and mortality rates
and also highlighted the issue of under-reporting of cases.
Dr. Barrientos also commented in the large dog population
in the country estimated between 3 to 3.5 million dogs.
The current control CE programmes that are initiatives of
the Ministry of Health of Chile were described, including
control programmes in the regions Coquimbo, Bio Bio,
Araucania, Aysen and Magallanes, plus a control campaign
in San Pedro de Melipilla (RM) (Fig. 1). The highest human
incidence is reported in the Aysén region (36.7/100,000 in-
habitants), followed by region XII, Magallanes (8.7/100,000
inhabitants), Araucania (8.4/100 inhabitants), BioBio (3.6/
100,000 inhabitants), Los Lagos (3.2/100,000 inhabitants)
and Coquimbo (2.6/100,000 inhabitants). Dr. Barrientos
also described the legal framework in which the notification
of human and animal disease is compulsory and discussed
the challenges for the future, including the maintenance of
the control initiatives, the extent of this initiatives to other
parts of the country, the need for reinforcing the intersec-
toral collaboration between the Ministry of Health, Agricul-
ture, councils and local communities and finally, to
facilitate the active involvement of the community.
Dr. Juan Francisco Álvarez (Servicio Agrícola Ganadero)
presented a detailed historical perspective of CE control
programmes carried out in the Magallanes region of Chile
between 1979–2004 aimed to decrease the infection levels
from 60% in sheep to under 10% in the first 10 years and
under 3% in the subsequent years. The main strategy of
the control programme was the use of praziquantel to-
gether with register of dogs, epidemiological surveillance
(presence of the parasite in dog faeces and sheep infec-
tion), sanitary control (control of entry of new dogs to the
region, building of infrastructure for local sacrifice of ani-
mals, in areas where there is no official abattoir, correct
disposal of viscera), public health education (avoid feeding
of dogs with offal, understanding of the life-cycle of the
parasite through local radio and schools), capacity build-
ing (laboratory facilities for diagnostic, training of staff in
diagnostic techniques), and finally the modification and
creation of laws and regulations that will sustain the
programme. The last treatment of dog was performed in
2004; since then an increase in the infection in sheep from
0.73% in 2004 to 2.64% in 2015 has been observed.
Dr. Marisa Torres (Pontificia Universidad Católica) de-
scribed the importance of CE affecting humans and how it
continues to being a neglected issue in Chile. Dr. Torres
also described how socioeconomic, cultural and environ-
mental conditions facilitate the transmission of this para-
site with emphasis on Chile. Special attention was devoted
to the lack of knowledge of this parasite and its transmis-
sion cycle among the farmers which continue to feed dogs
with offal and also the lack of anti-parasitic treatment to
dogs. Dr. Torres also highlighted how the poor communi-
ties, where the disease is highly prevalent, are neglected
and that usually the diagnosis of CE is late when is already
compromising the wellbeing of patients. Dr. Torres
emphasised the lack of standardization of diagnostic
methods, especially related with protocols for CE diagnos-
tic and categorization of the disease using ultrasound and
stressed the need for creating a national control plan inte-
grating animal and human health.
Ms. Maria Paz Aylwin (Instituto de Salud Pública (ISP),
National Reference Laboratory for Parasitology) summa-
rized the diagnostic activities carried out at the reference
laboratory in Chile. The ISP counts with an in house made
ELISA IgG and a Western blot used for monitoring the
antibody concentration pre- and post-surgical treatment of
patients. The ISP also provides copro PCR diagnostic service
amplifying sections of cox1 and 12S rRNA genes. The lab
has been training people coming from endemic countries in
South America in molecular diagnostics as part of the
Initiative from the control of CE supported by PAHO.
Highlights
Although CE receives attention by the authorities in Chile,
the disease persists and is an important neglected public
health issue affecting many people. The true extent of the
disease burden in the human population in Chile due to
CE remains unknown because of an under-reporting of
surgical cases. Challenges that remain for the future in-
clude: the sustainability of the initiatives of control into
the future, expansion of control programmes to the whole
country, improving and incentivising intersectoral work
and increasing the involvement of the community in these
initiatives. Regarding control programmes especially in
the southern region of the country (Magallanes), after
25 years of a successful control programme implementa-
tion that decreased substantially the infection rates in
sheep and dogs it has been observed an increase in the in-
fection in sheep from 0.73% in 2004 to 2.64% in 2015 (J.F.
Alvarez, personal communication).
Section 2: Current local and regional experiences in CE
control in Chile
Mr. Oscar Aguirre (Anthropologist representing the
Department of Epidemiology of the Ministry of Health
in the O’Higgins region) summarised the activities
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carried out in the region during the period 2008–2015.
The control programme currently underway in this re-
gion is based on educational activities. The programme
comprises eight municipalities with a total population of
59,394 inhabitants and includes training people in con-
trol activities; people attending the training sessions
come from different small organizations including
mostly education (schools), and health related organiza-
tions and neighbourhood associations. In total, 8,909
students from primary and secondary schools have re-
ceived instructions in prevention of CE in periodic visits
by the team of the Epidemiology Department of the
O’Higgins region. Mr. Aguirre described in detail these
activities and showed a number of images of the training
sessions and visits to schools in the region and also post-
ers summarizing the prevention measures for the infec-
tion with the parasite. Mr. Aguirre analysed the
challenges for the implementation of the programme.
Since the programme has been based on education of
the population in prevention of the disease, there is still
a need to identify the infected cases, treat them and
maintain a surveillance of the disease. It is expected the
programme will include one of the regional diagnostic
laboratories for the screening of the population. Another
challenge is the inclusion of more municipalities in the
programme and the inclusion of a qualitative assessment
of the measures implemented.
Dr. Maria Isabel Manriquez (Ministry of Health) pre-
sented the situation of CE in Araucanía region. In this
region an interdisciplinary committee was established in
2010; this committee proposed a control programme in-
volving a baseline study for E. granulosus prevalence in
dogs between 2011–2012, followed by deworming of
dogs every two months in an urban area and every four
months in the rural areas. The programme has focussed
on what is referred to as a cultural approach with the in-
clusion of representatives of the municipalities, INDAP,
SAG and community leaders all directed from the
regional section of the Ministry of Health. The results
reported a baseline of 13.6% of canine infection in 2012
that decreased to 4.6% in Lonquimay area in 2014 and
to 1.2% in rural areas in 2015. The programme has
included a number of activities with the Pehuenche indi-
genous community. Critical points identified in this
presentation included: the lack of inclusion of the con-
tents of the programme in classrooms in primary and
secondary schools, lack of regulations of dog ownership,
few alternatives for elimination of viscera, lack of pro-
grammes for spaying/neutering of dogs and failing in the
early diagnosis of human CE cases.
Dr. Claudia Adones (Ministry of Health) presented in-
sights of the control programme in the Coquimbo re-
gion, particularly in the councils of Punitaqui, Monte
Patria and Combarbala as part of a control programme
extending from 2015 to 2017. The programme involves
scientists from the Universidad Católica del Norte and the
Universidad Austral de Chile. The Universidad Católica
del Norte is delivering an educational programme for
school children and is also producing and disseminating
information related to CE prevention using local radio
and TV stations. The Universidad Austral de Chile is
responsible for the maintenance of a register of the dog
population, deworming and spaying/neutering of dogs
and the assessment of E. granulosus infections in canids
pre- and post-intervention strategies. The human popula-
tion that benefit with the control programme comprises
30,914 inhabitants. The dog population being treated and
registered is estimated to be between 15,425 and 28,045
dogs. The commitment of the municipalities and commu-
nities and staff involved in the programme was considered
to be a particular strength of the programme. Difficulties
caused by heavy rains and unpredictable natural events
such as earthquakes that are commonly occurring in Chile
have affected the delivery of the scheduled activities.
Dr. Sebastian Lillo (member of a governmental institu-
tion involved in the development of the agriculture in
Chile with emphasis on small producers, INDAP) pre-
sented a summary of the situation in the Biobio region
(Concepcion). The beneficiaries of INDAP are usually
people of advanced age with a low educational level and a
low financial income. Usually they have a small number of
animals that are part of an inefficient production system
with most of production being for self-consumption. The
presentation focussed on the difficulties regarding the
implementation of control measures in this environment
and also in how complex it is to change habits that per-
petuate the cycle.
Highlights
This session was extremely informative and highlighted the
substantial current efforts and commitment of the profes-
sionals from the Ministry of Health and the Ministry of
Agriculture working in the affected regions in attempts to
control CE. However, there is an agreement of a lack of
central coordination of the programmes. In terms of new
data, the presentations in this section provided information
on the current prevalence of dog infections in the different
areas of the country; these data are yet to be published in
the scientific literature.
Section 3: Contributions of Chilean scientists to the
control, biology and epidemiology of E. granulosus
Dr. Cristian Alvarez (University of Melbourne, Australia)
presented new unpublished data on the molecular
epidemiology of E. granulosus (s.s.) in Chile, describing a
higher variability than previously known, based on the
sequencing of 1,609 bp of the cox1 gene from isolates
from cattle, sheep and humans in a wide geographical
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area. The importance of characterising E. granulosus iso-
lates in animals that could harbour genotypes of the para-
site that could affect humans, especially goats and pigs for
the G6/7 variant of E. canadensis, which has been found
in around 10% of the human cases of CE worldwide [12].
Previous studies by Dr. Alvarez have highlighted the need
of studying the efficacy of the current EG95 vaccine
against different genotypes/species of E. granulosus, espe-
cially those able to infect humans [13].
Dr. Rodolfo Paredes (Universidad Andres Bello) sum-
marised his investigations on the role of the immune
system in the fertility of the cysts in cattle. In the first
part of his talk, Dr. Paredes showed the latest result ob-
tained in prevalence of cystic echinococcosis in bovines
slaughtered in Santiago, Chile. The unpublished data
showed a large predomination of infertile cyst; 61% of
the cysts were present only in lungs, with G1 as the
most important genotype present in Chile. In the second
part, Dr. Paredes presented previous research, showing
that germinal layer of infertile cysts presents IgG at least
an order of magnitude greater than in the germinal layer
of fertile cysts [14] with IgG1 being the predominant im-
munoglobulin subclass present in the germinal layer of
infertile cysts. This suggests that bovine production of
IgG1 subclass against parasite antigens present in the
germinal layer could be involved in the mechanism of
cyst infertility [15]. Finally, Dr. Paredes showed prelimin-
ary data on the immunological modulation in animals co-
infected with Fasciola hepatica. At the serological level,
co-infection raised the IL-4 level predominantly in infer-
tile cyst while at adventitial layer INF-ƴ increased at least
two-fold in infertile cyst.
Dr. Gerardo Acosta-Jamett (Universidad Austral de
Chile) summarized his studies on the epidemiology of
CE at the interphase of the urban and rural settings in
the Coquimbo region and highlighted the importance of
studying the dynamics of the dog population in any con-
trol intervention for this disease. The human:dog ratio
in the Coquimbo region varies between 1 and 2 in rural
areas and between 5 and 6 in the urban settings of the
cities Coquimbo and Ovalle [16]. He also showed data
referring to the presence of coproantigens in 7/28
“chilla” fox (Lycalopex griseus) in the Coquimbo region
[17]. Human prevalence, based in serological tests,
showed a rate of 2.6% (10/403) and a coproantigen test
in the same area of the Coquimbo region showed a rate
of 28% (26/93) for dogs [8].
Highlights
The session highlighted the efforts of three independent
Chilean researchers to continue the investigations related
to E. granulosus in three different areas: molecular
epidemiology, biology and epidemiology. There was an
agreement that the collaboration within Academia and be-
tween academics and the Ministry of Health, Ministry of
Agriculture, Government and policy and decision makers
is vital for the correct implementation of control interven-
tions for this neglected parasite in the near future.
Invited speakers
Melbourne Laureate Professor Marshall Lightowlers
(The University of Melbourne, Australia) delivered a
presentation on the “Alternatives for the control of
cystic echinococcosis”, providing a historical perspective
on the development of the EG95 vaccine and the contri-
bution of numerous researchers involved in the study of
CE worldwide. Together with the already known efficacy
of the vaccine [18, 19], he reported the use of the vac-
cine in field trials in Rio Negro, Argentina, and discussed
issues affecting the application of the vaccine in control
programmes [20, 21], including the lack of incentive for
livestock owners to vaccinate, the lack of animal hand-
ling facilities in many small farms where CE transmis-
sion is prevalent, the remote locations where control
programmes are often being undertaken, as well as diffi-
culties in the coordination of activities and the costs
involved, irrespective of the cost of the vaccine itself.
Dr. Francesca Tamarozzi (University of Pavia, Italy)
shared her experience in two aspects of the diagnosis of
human disease: serology and ultrasonography (US). The
general advantages of US are the low-cost, non-
invasivity, repeatability, ad being highly accepted by the
population, which is also sensitized as patients can see
the cyst (if present). In diagnosis and staging of abdom-
inal CE, US is the most accurate imaging tool compared
to Magnetic Resonance Imaging and computerised tom-
ography. Dr. Tamarozzi summarised the organization
and rationale of US surveys for CE carried out in Tibet
(PRC), Morocco, Perú, and most recently, within the EU
“HERACLES” project in three endemic countries in
eastern Europe. Important ethical issues to be consid-
ered before carrying out a population screening, as well
as the importance of training of local doctors and dis-
semination of the results, were especially highlighted.
Dr. Tamarozzi also described the WHO-IWGE (Informal
Working Group on Echinococcosis) consensus classifi-
cation of CE cysts and discussed the stage-specific
clinical management options. In a second presenta-
tion, Dr. Tamarozzi illustrated the difficulties in the
interpretation of the serology results for the diagnosis
and follow-up of CE. She stressed that serology has
only a complementary role to imaging, both in the
context of individual patients and of prevalence stud-
ies, where current serodiagnostic tests alone are not
appropriate to assess infection prevalence. Available
serological tests have unsatisfactory sensitivity and
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specificity; heterogeneous performances and results
are influenced by a number of variables, which needs
to be known when interpreting results. New areas of
research in this field include the use of recombinant
antigens and the detection of host cytokines.
Highlights
The presence of the invited speakers at the meeting
attracted high level of interest from the audience and was
a crucial factor on the success of this event. The talk by
Professor Lightowlers was the first of this kind in Chile to
a general audience involving not only academics but rep-
resentatives of the Ministry of Health and Agriculture.
Government representatives had the opportunity to hear
first-hand about the development of the EG95 vaccine
from a scientific and unbiased perspective. Since the usage
of the vaccine will begin in some areas in Chile during
2016 in pilot trials, the timely presence of Professor Light-
owlers highlighted the benefits of the inclusion of the
vaccine in a control programme but also pointed out some
difficulties in the practical implementation of its use, i.e.
difficulty accessing animals in remote places and the lack
of a commercial incentive for livestock owners to vaccin-
ate against cystic echinococcosis, hence the critical
importance of minimizing the cost of vaccination to the
livestock owners. His presentation revealed that to date,
after 20 years from the publication of the discovery of the
EG95 vaccine, there are very limited good quality data
available which assesses the real impact of the vaccine in
field conditions. Therefore, the control plans developed in
Chile that include vaccination are an opportunity to pro-
duce scientific evidence of the usefulness of the vaccine,
so it can be implemented in other parts of the world.
The contribution of Dr. Tamarozzi was highly appre-
ciated by the audience, she pointed out the need to estab-
lish ultrasound diagnostic in endemic poor areas. This is
not the case of Chile, country in which there are no
systemic data of mass ultrasound screening. Another
interesting situation highlighted by Dr. Tamarozzi was the
need for training of local doctors for the correct interpret-
ation of ultrasound scans. The presence of Dr. Tamarozzi
made evident a clear problem in Chile, i.e. the need for
increased collaboration between physicians and veterinar-
ians in the field of parasitology in general and especially in
the area of cystic echinococcosis. Among the few physi-
cians attending the meeting it was possible to discuss the
perspective of future collaborations in this area, including
the training in US diagnostic.
Round table
The second and last day of the meeting concluded with a
round table to answer the questions raised and to discuss
the alternatives for control of the disease and how they
can be implemented in Chile. The round table included
the invited speakers Professor Marshall Lightowlers and
Dr. Francesca Tamarozzi, plus the organizers of the event
Dr. Sandra Cortes, Dr. Fernando Fredes, Dr. Marisa
Torres, Dr. Gerardo Acosta-Jamett, Dr. Cristian Alvarez
and also the president of the Chilean Society for Parasit-
ology (SOCHIPA) Dr. Werner Apt.
Final remarks
 Among the participants at the meeting it was
evident during the round table discussions that a
positive energy and willingness exist to implement
actions against cystic echinococcosis. However, it is
also clear that the different control activities in
action in Chile were all using different approaches
and that there was very limited communication
between the groups involved.
 It was also evident that the control programmes face
difficulties in gaining support for sufficient periods of
time to ensure an enduring reduction in the incidence
of human disease. It is clear to all the participants of
the meeting that these control programmes have to
be in action for a long period with constant
reassessment of the results compared with the
baseline of the situation of the disease established
previous to the implementation of control measures.
 There is a need for the establishment of a
national programme calling experts in the field to
collaborate in the initiative. For this it is
necessary to establish clear roles for the sectors
involved: Universities, Government and privates,
this should consider epidemiological, social and
cultural aspects of what involves the
establishment of this kind of initiative.
 Regarding the implementation of the vaccine: (i)
due to the limitations in both the implementation
and assessment of field trials that have been
undertaken to date, we do not have sufficient,
reliable data to be able to recommend wide-scale
use of the EG95 vaccine for the control of CE;
(ii) there is an urgent need for new, scientifically
rigorous field assessments of the vaccine where
vaccinations can be delivered reliably to most
sheep and where sufficient numbers of sheep will
be available for necropsy so that an accurate
evaluation can be made of the vaccine’s usefulness
as a CE control tool.
 It was agreed that abdominal ultrasound screening
of human populations in Chile at risk of CE should
be undertaken, allowing early treatment of cases and
a more accurate determination of the prevalence of
infection in the human population. An increased
involvement by physicians in the control
programmes in Chile is necessary as well as
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increased interaction with the veterinary sector
involved in these programmes.
 In order to continue and enhance the systematic
study of E. granulosus and its control in Chile, the
Chilean organizers of the meeting proposed
establishment of a “Cystic Echinococcosis Group in
Chile” as an open and cooperative group which can
coordinate activities, organise future meetings,
prepare applications for research funding and
continue the extension of activities and publishing
the results obtained in research activities. The group
would seek to collaborate with the government
authorities in the design and improvements of the
control plans for the disease in Chile.
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